2020
DOI: 10.1177/0956462420933716
|View full text |Cite
|
Sign up to set email alerts
|

Long-term virological effectiveness with darunavir/ritonavir-based salvage therapy in people living with HIV/AIDS from São Paulo, Brazil

Abstract: Even though darunavir/ritonavir (DRV/r) has high potency and a greater genetic barrier, there are few studies on the long-term effectiveness of DRV/r-based salvage therapy in people living with HIV (PLWH) in low and middle-income countries. This retrospective cohort study, from São Paulo, Brazil, included ART-experienced PLWH aged ≥18 years with virological failure (VF) who had started DRV/r plus an optimized background regimen (OBR) between 2008 and 2012. The proportion of patients with viral load (VL) <50… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 22 publications
(50 reference statements)
0
2
0
Order By: Relevance
“…DRV is a non-peptide compound that is proven to have potent activity against drug-resistant HIV-1 strains ( Ghosh et al, 2007 ; Kovalevsky et al, 2008 ). So, it has been widely used in AIDS treatment ( Chow et al, 2020 ; Navarro et al, 2020 ; Santos et al, 2020 ). However, there are some mutations that lead to resistance of the HIV-1 PR to DRV.…”
Section: Introductionmentioning
confidence: 99%
“…DRV is a non-peptide compound that is proven to have potent activity against drug-resistant HIV-1 strains ( Ghosh et al, 2007 ; Kovalevsky et al, 2008 ). So, it has been widely used in AIDS treatment ( Chow et al, 2020 ; Navarro et al, 2020 ; Santos et al, 2020 ). However, there are some mutations that lead to resistance of the HIV-1 PR to DRV.…”
Section: Introductionmentioning
confidence: 99%
“…As a non-peptide compound, it is proved to have a potent activity against the drug-resistant HIV-1 strains 31,32 . So, it has been widely used in AIDS treatment [33][34][35] . However, there are some mutations that lead to resistance of the HIV-1 PR to Darunavir.…”
Section: Introductionmentioning
confidence: 99%